These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9566425)

  • 21. Are African American patients at a higher risk for olanzapine-induced glucose intolerance?
    Ananth J; Gunatilake S; Aquino S; Bach V; Costa J
    Psychopharmacology (Berl); 2001 Sep; 157(3):324-5. PubMed ID: 11605090
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy should drive atypical antipsychotic treatment.
    Citrome LL
    BMJ; 2003 Feb; 326(7383):283. PubMed ID: 12561827
    [No Abstract]   [Full Text] [Related]  

  • 23. Olanzepine-induced tardive dyskinesia.
    Bella VL; Piccoli F
    Br J Psychiatry; 2003 Jan; 182():81-2. PubMed ID: 12509329
    [No Abstract]   [Full Text] [Related]  

  • 24. Olanzapine-induced bilateral pedal edema: a case report.
    Yovtcheva SP; Yazel JJ
    Gen Hosp Psychiatry; 2000; 22(4):290-1. PubMed ID: 11023366
    [No Abstract]   [Full Text] [Related]  

  • 25. Speech disturbance and marked decrease in function seen in several older patients on olanzapine.
    Gaile S; Noviasky JA
    J Am Geriatr Soc; 1998 Oct; 46(10):1330-1. PubMed ID: 9777929
    [No Abstract]   [Full Text] [Related]  

  • 26. Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine.
    Hägg S; Mjörndal T; Lindqvist L
    J Clin Psychopharmacol; 2001 Feb; 21(1):113-5. PubMed ID: 11199936
    [No Abstract]   [Full Text] [Related]  

  • 27. Pustular eruption induced by olanzapine, a novel antipsychotic agent.
    Adams BB; Mutasim DF
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):851-3. PubMed ID: 10534668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotic drugs and hyperglycemia in adolescents.
    Koller E; Malozowski S; Doraiswamy PM
    JAMA; 2001 Nov; 286(20):2547-8. PubMed ID: 11722267
    [No Abstract]   [Full Text] [Related]  

  • 29. Olanzapine-associated priapism.
    Childers JB; Schwartz AC; Compton MT
    Psychosomatics; 2003; 44(4):351-2. PubMed ID: 12832606
    [No Abstract]   [Full Text] [Related]  

  • 30. Benefits of olanzapine as first-line schizophrenia therapy.
    Cohen LJ
    Am J Health Syst Pharm; 1999 Aug; 56(15):1559-60, 1563-4. PubMed ID: 10478999
    [No Abstract]   [Full Text] [Related]  

  • 31. Fever, delirium, autonomic instability, and monocytosis associated with olanzapine.
    Robinson RL; Burk MS; Raman S
    J Postgrad Med; 2003; 49(1):96. PubMed ID: 12865583
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of Parkinson disease.
    Mandanas L
    J Am Board Fam Pract; 1998; 11(2):171. PubMed ID: 9542714
    [No Abstract]   [Full Text] [Related]  

  • 33. Case report of withdrawal syndrome after olanzapine discontinuation.
    Nayudu SK; Scheftner WA
    J Clin Psychopharmacol; 2000 Aug; 20(4):489-90. PubMed ID: 10917413
    [No Abstract]   [Full Text] [Related]  

  • 34. Olanzapine-induced thrombocytopenia in association with idiopathic thrombocytopenic purpura.
    Bachmann S; Schröder J; Pantel J; Mundt C; Zorn M; Witzens M; Egerer G
    Br J Psychiatry; 1998 Oct; 173():352. PubMed ID: 9926044
    [No Abstract]   [Full Text] [Related]  

  • 35. Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy.
    Ascari-Raccagni A; Baldari U; Rossi E; Alessandrini F
    J Eur Acad Dermatol Venereol; 2000 Jul; 14(4):315-6. PubMed ID: 11204528
    [No Abstract]   [Full Text] [Related]  

  • 36. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of olanzapine with fluvoxamine.
    de Jong J; Hoogenboom B; van Troostwijk LD; de Haan L
    Psychopharmacology (Berl); 2001 May; 155(2):219-20. PubMed ID: 11401013
    [No Abstract]   [Full Text] [Related]  

  • 39. Olanzapine: hematological reactions.
    CMAJ; 1998 Jul; 159(1):81-2, 85-6. PubMed ID: 9679498
    [No Abstract]   [Full Text] [Related]  

  • 40. Olanzapine-associated seizure.
    Bonelli RM
    Ann Pharmacother; 2003 Jan; 37(1):149-50. PubMed ID: 12503952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.